SOHO 2023 | Defining elderly patients in the context of DLBCL treatment
Pallawi Torka, MD, Memorial Sloan Kettering Cancer Center, New York City, NY, discusses the definition of elderly patients in the context of diffuse large B-cell lymphoma (DLBCL) treatment. Dr Torka comments on the use of age cut-offs to determine eligibility for DLBCL treatment in clinical trials, before highlighting the need to group older patients according to biological age instead. It is thought that fit older patients could be eligible for the same treatment as younger adult patients. This interview took place at the Eleventh Annual Meeting of the Society of Hematologic Oncology (SOHO 2023) held in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Consultancy fees from Genentech, Genmab, Seagen, ADC therapeutics, TG therapeutics, Lilly USA.
